About this trial
The investigator hypothesize that low-dose MDMA (3,4-methylenedioxymethamphetamine) will produce a sufficiently strong oxytocin stimulation in healthy controls and no relevant increase in patients. This study will confirm previously published data and provide important safety data with low-dose MDMA stimulation testing.
Eligibility criteria
Qualifiers
Adult healthy controls
Matched for age, sex, Body mass index, and oestrogen replacement/menopause/hormonal contraceptives to patients
No medication, except hormonal contraception
Disqualifiers
Participation in a trial with investigational drugs within 30 days
Illicit substance use (except for cannabis) more than 10 times in lifetime or any time within the previous two months
Consumption of alcoholic beverages >15 drinks/week
Tobacco smoking >10 cigarettes/day
Trial design
Treatments tested in this trial
- MDMA
- Placebo